Skip to main content
. 2019 Aug 23;11(9):429. doi: 10.3390/pharmaceutics11090429

Scheme 1.

Scheme 1

Schematic illustration of the preparation of the RBCM-p-PLGA@Cur NPs, and their anti-tumor effects. Abbreviations: RBC, red blood cell; RBCM, red blood cell membrane; Cur, curcumin; p-PLGA, porous poly(lactic-co-glycolic acid) nanoparticles; p-PLGA@Cur NPs, curcumin-loaded porous poly(lactic-co-glycolic acid nanoparticles); RBCM-p-PLGA@Cur NPs, red blood cell membrane cloaked curcumin-loaded porous poly(lactic-co-glycolic acid) nanoparticles.